123 Accelerator Announces Investments in Virology Start-Up Trawsfynydd’s Novel Virology Programs
123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced investments in a virology start-up Trawsfynydd Therapeutics, together with OrbiMed Advisors.
123 Accelerator Announces the Launch of Gwynant Therapeutics and Celyn Therapeutics to Develop Novel Small Molecules for Oncology Targets
123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced two new start-up investments together with OrbiMed Advisors.